Keywords: آنتی بادیهای ناتریال; Zika virus; Dengue virus; Immunity; Flaviviruses; Neutralizing antibodies; Antibody-dependent enhancement; Cross-reactivity; Memory B cells; T cells; Envelope protein; Monoclonal antibody; Polyclonal antibody response; Structural immunology;
مقالات ISI آنتی بادیهای ناتریال (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی بادیهای ناتریال; ANOVA; analysis of variance; ASC; antibody secretory cells; AUC; area under the curve; dpi; days post-infection; dpv; days post-vaccination; FMD; foot and mouth disease; FMDV; foot and mouth disease virus; HRP; horseradish peroxidase; LPBE; liquid-phase b
Keywords: آنتی بادیهای ناتریال; Herd immunity; vaccination; neutralizing antibodies;
Keywords: آنتی بادیهای ناتریال; Zika virus; Seroprevalence; NS1 ELISA; Neutralizing antibodies; Africa; Phylogeny;
Keywords: آنتی بادیهای ناتریال; HSV; HCMV; Surface antigens; Neutralizing antibodies;
Keywords: آنتی بادیهای ناتریال; Flavivirus; Ticks; Neutralizing antibodies; IVIG; Antibody-dependent enhancement; Immunotherapy;
Keywords: آنتی بادیهای ناتریال; Severe fever with thrombocytopenia syndrome virus; Vaccine; Neutralizing antibodies; Standard viral strain; CPE; cytopathic effect; NTAbs; neutralizing antibodies; SFTS; severe fever with thrombocytopenia syndrome; SFTSV; SFTS virus;
Keywords: آنتی بادیهای ناتریال; Grouper; Betanodavirus; Inactivated vaccine; Neutralizing antibodies; Interlukin-1β;
Keywords: آنتی بادیهای ناتریال; Antibody production; IgG avidity test; Neutralizing antibodies; Patients' follow-up; Toscana virus infection;
Keywords: آنتی بادیهای ناتریال; Anti-drug antibodies; Neutralizing antibodies; Bioassay; Luciferase; Interferon beta; Multiple sclerosis;
Keywords: آنتی بادیهای ناتریال; Adenovirus; Albumin; Albumin-binding domain; Neutralizing antibodies;
Keywords: آنتی بادیهای ناتریال; ADA; anti-drug antibody; ACP; assay cutpoint; CDM; compact disc microstructures; CDR; complementary determining region; Fc; Fragment crystallizable; F/T; ratio of free to total drug concentrations; iNAb; indirect NAb assessment; LLRD; lower limit of relia
Keywords: آنتی بادیهای ناتریال; ALV-J; Multi-epitope vaccine; Immunogenicity; Neutralizing antibodies; T-lymphocytes
Keywords: آنتی بادیهای ناتریال; Immunogenicity; Therapeutic proteins; Neutralizing antibodies; Quantitation; Neutralizing capacity;
Keywords: آنتی بادیهای ناتریال; Hand, foot and mouth disease (HFMD); Human enterovirus 71 (EV71); Coxsackievirus A16 (CVA16); Vaccine; Neutralizing antibodies;
Keywords: آنتی بادیهای ناتریال; CIS; clinically isolated syndrome; CPS; control preference scale; DMTs; disease modifying therapies; JCV; JC virus; MRI; magnetic resonance imaging; MSDS 3D; Multiple Sclerosis Documentation System 3D; MSIF; Multiple Sclerosis International Federation; NA
Keywords: آنتی بادیهای ناتریال; Nipah virus; Vaccines; Recombinant vesicular stomatitis virus; Humoral immune responses; Neutralizing antibodies; Serum transfer;
Keywords: آنتی بادیهای ناتریال; HCMV; human cytomegalovirus; ORF; open reading frame; SOT; solid organ transplant; HSCT; hematopoietic stem cell transplant; Râ/D+; a HCMV seronegative recipient with SOT from a seropositive donor; MVV; modified virus vaccine; IAV; individual antigen va
Keywords: آنتی بادیهای ناتریال; West Nile virus; Surveillance; Early warning; Greece; Central Macedonia; Juvenile domestic pigeons; WNV point seroprevalence; Neutralizing antibodies; Incidence rates of human WNND; Usutu virus
Keywords: آنتی بادیهای ناتریال; HIV vaccines; Neutralizing antibodies; Binding antibodies; T cells; Viral vector; Protein boost; DNA prime;
Keywords: آنتی بادیهای ناتریال; Adeno-associated virus; Neutralizing antibodies; Passive immunity;
Keywords: آنتی بادیهای ناتریال; Porcine reproductive and respiratory syndrome; Vaccination; Cell-mediated immunity; Neutralizing antibodies;
Keywords: آنتی بادیهای ناتریال; Neutralizing antibodies; Inactivated vaccine; Efficacy; NSP; r1 value;
Keywords: آنتی بادیهای ناتریال; Ad; adenovirus; rAd; recombinant adenovirus; WT; wild-type; E1; early region 1; E4; early region 4; HBsAg; hepatitis B virus surface antigen; hr404; host range mutation in DNA binding protein; rAd5hr; recombinant Ad 5 with hr404 mutation; Ad5hrSIVenv/rev;
Keywords: آنتی بادیهای ناتریال; Plasma therapy; Convalescent plasma; Neutralizing antibodies; Therapeutic plasma; Infectious disease; Transfusion; Ebolavirus infectionPlasmathérapie; Plasma convalescent; Anticorps neutralisants; Plasma thérapeutique; Maladies infectieuses; Transfusion;
Keywords: آنتی بادیهای ناتریال; CTB, cholera toxin B subunit; CT, cholera toxin; FA, fluid accumulationCholera; Low-cost vaccine; Oral immunization; Cold chain; Neutralizing antibodies; Cholera toxin
A comparative study between outbred and inbred rat strains for the use in in vivo IPV potency testing
Keywords: آنتی بادیهای ناتریال; Inactivated poliovirus vaccine; Animal model; Sabin; Salk; Neutralizing antibodies; Immunogenicity; ELISA; enzyme-linked immunosorbent assay; EP; European Pharmacopoeia; GMT; geometric mean antibody titer; IPV; inactivated poliomyelitis vaccines; OPV; ora
Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta
Keywords: آنتی بادیهای ناتریال; Multiple sclerosis; Interferonβ; Neutralizing antibodies; NABs; PEGylated IFNβ; Plegridy;
Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection
Keywords: آنتی بادیهای ناتریال; RSV; Neutralizing antibodies; Vaccine; Microneutralization assay;
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy
Keywords: آنتی بادیهای ناتریال; Hepatitis C; Relapse; Direct-acting antivirals; Neutralizing antibodies; Sustained virological response; E1E2 envelope; HCV; hepatitis C virus; DAA; direct-acting antiviral; SVR; sustained virological response; RBV; ribavirin; PEG-IFN; pegylated-interfero
Inactivated and live bivalent fowl adenovirus (FAdV8bâ¯+â¯FAdV11) breeder vaccines provide broad-spectrum protection in chicks against inclusion body hepatitis (IBH)
Keywords: آنتی بادیهای ناتریال; dph; days post-hatch; dpv; days post-vaccination; EID50; embryo infectious dose 50; FAdV; fowl adenovirus; HHS; hepatitis-hydropericardium syndrome; IBH; inclusion body hepatitis; LMH; leghorn male hepatoma; MtAb; maternal antibodies; NAb; neutralizing an
Antibodies to in silico selected GPI-anchored Theileria parva proteins neutralize sporozoite infection in vitro
Keywords: آنتی بادیهای ناتریال; Theileria; Sporozoites; Antigens; Neutralizing antibodies; Vaccine;
High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test
Keywords: آنتی بادیهای ناتریال; Filoviridae; Immune response; Neutralizing antibodies; Replication-competent recombinant vesicular stomatitis virus; Glycoprotein; Green fluorescence protein;
Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs
Keywords: آنتی بادیهای ناتریال; Vaccine; Swine; Influenza; Route; Neutralizing antibodies; Protection;
Reprint of “Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab”
Keywords: آنتی بادیهای ناتریال; AS; ankylosing spondylitis; ATA; anti-therapeutic antibodies; BASDAI; Bath Ankylosing Spondylitis Disease Activity Index; DAS28; Disease Activity Score 28; DMARDs; disease-modifying antirheumatic drugs; ECL; electrochemiluminescence; LoD; limit of detecti
Human monoclonal antibodies neutralizing influenza virus A/H1N1pdm09 and seasonal A/H1N1 strains - Distinct Ig gene repertoires with a similar action mechanism
Keywords: آنتی بادیهای ناتریال; IFV; influenza virus; HA; hemagglutinin; MAbs; monoclonal antibodies; hMAb; human monoclonal antibodies; Nabs; neutralizing antibodies; hnMAbs; human neutralizing monoclonal antibodies; HIV; human immunodeficiency virus; HI; hemagglutination inhibition; s
Interferon-beta specific T cells are associated with the development of neutralizing antibodies in interferon-beta treated multiple sclerosis patients
Keywords: آنتی بادیهای ناتریال; Interferon beta; Multiple sclerosis; Neutralizing antibodies; T cell; Antigenic epitope; Anti-drug antibodies;
Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5â¯years of treatment
Keywords: آنتی بادیهای ناتریال; Morquio A; Mucopolysaccharidosis IVA; Long-term extension; Elosulfase alfa; 3MSCT; 3-min stair climb test; 6MWT; 6-min walk test; AE; adverse event; AUC0ât; area under the curve from time 0 to last measurable concentration; AUCinf; area under the curve
Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles
Keywords: آنتی بادیهای ناتریال; Protein stability; Immune focusing; Neutralizing antibodies; Vaccine; Nanoparticles; CD4bs; CD4 binding site; OD; outer domain; Env; envelope glycoprotein; CP; capsid protein; VLPs; virus-like particles; PBS; phosphate buffer saline; Cys; cysteine; SMCC;
Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
Keywords: آنتی بادیهای ناتریال; Cytomegalovirus; mRNA vaccine; Pentameric complex; Neutralizing antibodies; Cytogam;
Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity
Keywords: آنتی بادیهای ناتریال; Epitopes; Human adenovirus type 14; Human adenovirus type 55; Neutralizing antibodies; Vaccine;
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
Keywords: آنتی بادیهای ناتریال; ACMG; American College of Medical Genetics and Genomics; ADHD RS-IV IA; Attention Deficit Hyperactivity Disorder Rating Scale IV inattention subscale; AE; adverse event; CTCAE; Common Terminology Criteria for Adverse Events; DMC; Data Monitoring Committee
In vitro models for immunogenicity prediction of therapeutic proteins
Keywords: آنتی بادیهای ناتریال; Therapeutic protein; Immunogenicity assessment; In vitro model; Subcutaneous injection; Injection site reactions; ADAs; antidrug antibodies; ALN; artificial lymph node; APCs; antigen presenting cells; ASCs; adipose-derived stem/stromal cells; DCs; dendrit
Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge
Keywords: آنتی بادیهای ناتریال; PRRSV; Neutralizing antibodies; Cross-protection; Passive transfer; Neutralizing epitope; Swine;
Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies
Keywords: آنتی بادیهای ناتریال; HCV; Hepatitis C virus; Cell culture; In vitro; Full-length HCV; Chimeric HCV; HCV treatment in vitro; HCV vaccine; Pseudo-particle; Replicon; HCVcc; Neutralizing antibodies; Direct acting antivirals; DAA;
Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization
Keywords: آنتی بادیهای ناتریال; CMV primary infection; Neutralizing antibodies; Hyperimmunogloblulin (HIG); Standard immunoglobulin; Recombinant immunoblot; Pregnancy;
Systematic analysis of botulinum neurotoxin type A immunogenicity in clinical studies
Keywords: آنتی بادیهای ناتریال; ABO; abobotulinumtoxinA; BoNT; botulinum neurotoxin; BoNT-A; botulinum neurotoxin type A; INCO; incobotulinumtoxinA; MDA; mouse diaphragm assay; MPA; mouse protection assay; NAb; neutralizing antibodies; ONA; onabotulinumtoxinA; Botulinum toxin; BoNT-A; I
Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibody
Keywords: آنتی بادیهای ناتریال; Sudan virus; Ebola virus; Neutralizing antibodies; Synthetic antibodies;
Immunogenicity and protective efficacy of virus-like particles and recombinant fiber proteins in broiler-breeder vaccination against fowl adenovirus (FAdV)-8b
Keywords: آنتی بادیهای ناتریال; CTL; cytotoxic T-cell-mediated immunity; TCID50; tissue culture infective dose 50; PBMC; peripheral blood mononuclear cells; H&E; hematoxylin and eosin; FAdV; fowl adenovirus; MtAb; maternal antibodies; NAb; neutralizing antibodies; VLPs; virus-like parti
Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies
Keywords: آنتی بادیهای ناتریال; Herpes simplex; Vaccine; Live-attenuated; Germinal center; B cell; T cell; Rhesus macaques; Neutralizing antibodies; Humoral immunity; Cellular immunity;